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A B S T R A C T   
Prenatal testosterone (pT) is a crucial component in physiological masculinization in humans. In line with the 
Prenatal Sex Steroid Theory of autism, some studies have found a positive correlation between pT and autistic 
traits in childhood. However, effects in adolescence have not been explored. Hormonal and environmental 
changes occurring during puberty may alter the strength or the nature of prenatal effects on autistic traits. The 
current study examines if pT relates to autistic traits in a non-clinical sample of adolescents and young adults (N 
= 97, 170 observations; age 13–21 years old). It also explores pT interactions with pubertal stage and timing. PT 
concentrations were measured from amniotic fluid extracted in the 2nd trimester of gestation via amniocentesis 
conducted for clinical purposes. Autistic traits were measured by self- and parent-reports on the Autism Spectrum 
Quotient (AQ) which provides a total score and 5 sub-scores (social skills, communication, imagination, attention 
switching and attention to detail). Self-reported pubertal stage was regressed on age to provide a measure of 
relative timing. We found no statistical evidence for a direct association between pT and autistic traits in this 
adolescent sample (males, females or full sample). Exploratory analyses suggested that pT correlated positively 
with autistic traits in adolescents with earlier puberty-onset, but statistical robustness of this finding was limited. 
Further exploratory post-hoc tests suggested the pT-by-pubertal timing interaction was stronger in males relative 
to females, in self-reported compared to parent-reported AQ and specifically for social traits. These findings 
require replication in larger samples. Findings have implications for understanding the effects of pT on human 
behavior, specifically existence of effects in adolescence.   
1. Introduction 
1.1. pT and autistic traits 
Autism Spectrum Conditions (henceforth, autism) are the spectrum 
of phenotypes characterized by differences in social interaction, 
communication, adjusting to unexpected change, alongside unusually 
restricted and repetitive behavior, focused or intense interests, and 
sensory differences. Autism is more commonly diagnosed in males than 
females (Loomes et al., 2017). In the general population, males also 
report more autistic traits than females (Baron-Cohen et al., 2001; 
Greenberg et al., 2018). This has raised the question whether prenatal 
testosterone (pT), a masculinizing factor, contributes to the develop-
ment of autism (Baron-Cohen et al., 2011). 
Some support for the link between pT and autistic traits has come 
from several study designs. First, correlations have been reported be-
tween pT found in amniotic fluid and parent-reported autistic traits in 
childhood (Auyeung et al., 2012, 2009b, 2010), parent-reported 
empathy, theory of mind (Chapman et al., 2006), restricted interests 
(Knickmeyer et al., 2005) and early social behaviors (Lutchmaya et al., 
2002; Knickmeyer et al., 2005, 2006b). Amniotic derived pT is partic-
ularly valuable as the clinical amniocentesis overlaps with a critical time 
of gestation when pT levels show sex differences (van de Beek et al., 
2004), sexual differentiation of the brain occurs (Goy et al., 1988; 
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Roselli et al., 2011) and autism-related genes show the highest expres-
sion (gestational weeks 10–25; Grove et al., 2019). However, one in-
dependent study found no relationship between amniotic-derived pT 
and parent-reported autistic traits (Kung et al., 2016b, 2016a). Differ-
ences in sample or methodology may account for the inconsistent find-
ings between Auyeung et al. (2009b) and Kung et al. (2016b), (2016a) 
which both used the Childhood Autism Spectrum Test (CAST) as their 
outcome. 
Second, Congenital Adrenal Hyperplasia (CAH) is an autosomal 
recessive disorder characterized by cortisol deficiency and elevated 
androgens beginning prenatally. This elevation is particularly marked in 
females with CAH. Males with CAH have normal to high androgen 
concentrations prenatally. Two studies found that girls with CAH score 
higher on measures of autistic traits than matched relatives (Knickmeyer 
et al., 2006a; Kung et al., 2016a), however, Kung et al. did not find this 
difference to be significant and the difference in Knickmeyer et al. were 
small and driven by one AQ sub-scale (imagination). Engberg et al. 
(2015) also found that neuropsychiatric diagnoses in general, but not 
autism specifically, were more common among females with CAH (n =
335; ages 15–37) compared to controls. Finally, Güneş et al. (2020) 
found that boys (n = 18) but not girls (n = 27) with CAH showed higher 
autistic traits as measured by the Social Communication Questionnaire 
compared to non-autistic relatives. The CAH research is therefore mixed 
regarding increased likelihood of autistic traits. 
Third, an association between pT and autism is supported by studies 
on children of mothers with Polycystic Ovary Syndrome (PCOS), a 
condition characterized by excess circulating androgens. A meta- 
analysis found maternal PCOS increases the odds of an autism diag-
nosis in their children by 66% (Katsigianni et al., 2019), an effect which 
appears to be independent from genetic factors related to PCOS (Cesta 
et al., 2020). However children of women with PCOS are also at 
increased odds of developing other conditions such as ADHD, sleeping, 
eating and mood-related conditions, which suggests the effect is not 
specific to autism or more male-skewed conditions (Chen et al., 2020; 
Berni et al., 2018). Furthermore, no other maternal condition linked 
with heightened early androgens has been reliably associated with a 
diagnosis of autism in their children (May et al., 2021). 
Fourth, masculinized morphology may be associated with autism. 
Male-type shifts in the facial morphology of autistic individuals have 
been reported compared to their non-autistic peers (Tan et al., 2017, 
2020a, 2020b) and sex differences in brain structure and function in 
autistic adults are attenuated, with male-type shifts in specific regions 
(Floris et al., 2018; Lai et al., 2013). However, not all studies have found 
associations between male-typical morphology and autistic traits in a 
direction consistent with increased pT (Kung et al., 2021; Smith et al., 
2019; Alaerts et al., 2016; Lee et al., 2020; Bejerot et al., 2012). 
The timing of pT measurement may be important. Studies measuring 
testosterone from umbilical cord blood or infant saliva have not found 
associations with autistic traits (Whitehouse et al., 2012a; Park et al., 
2017; Auyeung et al., 2012; Kung et al., 2016b). Cord-derived pT is also 
influenced by obstetric noise from labor and glucocorticoid treatment 
(Keelan et al., 2012). However, the sex difference in umbilical cord 
testosterone remains significant (Barry et al., 2011) and testosterone 
levels at this point appear to be relevant to other aspects of child 
development such as speech and language (Whitehouse et al., 2012b; 
Hollier et al., 2013). 
Two main caveats surround the association between pT and autistic 
traits. First, studies using the Danish Biobank found no significant dif-
ference in amniotic fluid testosterone between autistic and non-autistic 
boys, showing that other steroid hormones beyond pT are likely 
involved (Baron-Cohen et al., 2015, 2019). This has led to a broadening 
of the Fetal Testosterone theory of autism to the Prenatal Sex Steroid 
theory. Second, there has been a shortage of studies linking 
amniotic-derived pT and autistic traits due to ethical and practical dif-
ficulties of obtaining amniotic fluid and as a result most studies have 
come from one sample pool (Cambridgeshire, UK) and one lab (Xiong 
and Scott, 2020). Yet pT remains a plausible predictor of autistic traits 
given (i) the pervasive sex difference in autism (Loomes et al., 2017), (ii) 
the potential for pT to interact with known likelihood factors for autism, 
the majority of which also occur in gestation (Emberti Gialloreti et al., 
2019) and (iii) the dimensional nature of pT whose distribution across 
the population may map onto to the autism spectrum. The future of 
research into pT as a predictor of autistic traits is therefore likely to focus 
on the interactions between pT and other predisposing factors such as 
familial/genetic and developmental factors. 
1.2. pT and autistic traits beyond puberty 
One unknown is whether pT exposure can impact behavior beyond 
childhood and into adolescence. To date, all studies on amniotic pT and 
autistic traits have assessed outcomes in mostly pre-pubertal children, 
but it is possible that the hormonal and neuronal changes of puberty 
could interact with the initial effect of pT on neurodevelopment. Puberty 
may alter the number or strength of autistic traits, particular social 
traits. Adolescence is a time of accelerated structural and functional 
change in the brain, partially mediated by the increase in sex hormones 
and resulting in a hypersensitivity to social stimuli (Goddings et al., 
2012; Blakemore, 2012; Foulkes and Blakemore, 2016). However it is 
not well understood how puberty affects autistic traits. One longitudinal 
study of autistic people reported that a sub-group (17%) had signifi-
cantly poorer outcome after puberty (Billstedt et al., 2005) while 
another found a general improvement in parent-reported behaviors in 
their autistic children during adolescence (McGovern and Sigman, 
2005). 
There is some evidence to suggest the effects of pT on brain structure 
and function are altered during adolescence. Twins sharing the womb 
with a male, who are thought to be exposed to higher levels of pT, have 
larger total brain volumes at age 9 (e.g., females with male twins have 
larger brain volumes than females with female twins). However, this 
effect of pT on brain volumes was attenuated and non-significant in 
adults suggesting it may be developmentally specific (Peper et al., 
2009). Beking et al. (2018) found that there was an interaction between 
amniotic-based pT and pubertal testosterone on a male-typical pattern 
of neural lateralization during a mental rotation task, which may also 
indicate a developmentally sensitive effect of pT on brain function. 
Pubertal timing (in particular early-onset or precocious puberty) has 
also shown consistent associations with mental health difficulties in 
adolescence (Dorn, 2007; Kaltiala-Heino et al., 2003; Mendle et al., 
2010; Wichstrøm, 2000) and may interact with behavioral effects of pT. 
Animal experiments suggest puberty may be a second sensitive 
period of neuroendocrine organization (Romeo, 2003; Schulz et al., 
2009). Manipulation of pubertal testosterone alters sex-typical social 
and anxiety behaviors in the Syrian hamster (Schulz et al., 2009) and 
social stressors during puberty (but not in late adolescence) can enhance 
neurological insults conferred by gestational infection (“two-hit hy-
pothesis”; Giovanoli et al., 2013), a mechanism which some researchers 
posit may be relevant to autism (Picci and Scherf, 2015). 
Taken together, these animal and human studies highlight the 
importance of taking puberty into account when assessing the behav-
ioral effects of pT in adolescence. 
1.3. The current study 
We test whether pT is related to scores on the Autism Spectrum 
Quotient (AQ) in individuals aged 13–21. This is a follow-up of the 
longitudinal study of neurotypical children whose pT was measured 
from amniotic fluid during gestation and who were assessed for autistic 
traits as infants (Lutchmaya et al., 2001, 2002) and children, up to age 
10 (Chapman et al., 2006; Knickmeyer et al., 2005, 2006b; Auyeung 
et al., 2006, 2009b). We assess whether pT is associated with each AQ 
subscale (social skills, communication, imagination, attention to detail, 
and attention-switching) as a previous study suggests (Auyeung et al., 
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2009b). We control for two measures of pubertal development: pubertal 
stage, whose order is consistent across most individuals, and pubertal 
timing, which can vary widely between individuals. We hypothesize that 
pT will be positively correlated with AQ total score, in keeping with 
previous results in younger children (Auyeung et al., 2009b, 2010, 
2012). We also explore the relative effects of pT on each AQ subscale and 
whether pubertal factors have any effect on the pT-AQ relationship. 
2. Material and methods 
2.1. Participants and procedure 
Mothers in Cambridgeshire (UK) who had undergone a routine 
amniocentesis for clinical purposes (1996–1999) and who gave birth to 
healthy singletons were invited to take part in a study on the effects of 
pT on the child’s cognition, behavior and brain development (Baron--
Cohen et al., 2004). Those who consented allowed their amniotic fluid to 
be retrospectively analyzed for testosterone. Children who screened 
positive for a genetic abnormality at the amniocentesis or later were 
excluded. Between 2012 and 2018, 105 participants returned for testing, 
where they completed a range of cognitive tests and questionnaires. Five 
participants were excluded because of pT values (see below) and a 
further 3 individuals did not complete an AQ, leaving 97 individuals and 
170 AQ score observations for analysis (56 males with 96 AQ scores, 41 
females with 74 scores). Demographic details of the sample are provided 
in Table 1. For participants under 18, parents provided informed consent 
and participants provided informed assent. Those over 18 provided their 
own consent and completed only self-report AQ. This study was 
approved by the Essex 1 National Research Ethics committee. 
2.2. Prenatal testosterone (pT) 
PT concentration was measured via radioimmunoassay in amniotic 
fluid samples collected between 13 and 20 weeks of gestation (Lutch-
maya et al., 2001). Amniotic fluid was extracted with diethyl ether, 
which was evaporated to dryness at room temperature and the extracted 
material re-dissolved in an assay buffer. Testosterone was assayed by the 
Count-a-Coat method (Diagnostic Product), which uses an antibody to 
testosterone coated onto propylene tubes and a 125I-labeled testos-
terone analog. The detection limit of the assay using the ether-extraction 
method is 0.05 nmol/L. The coefficient of variation (CV) for 
between-batch imprecision is 19% at a concentration of 0.8 nmol/L and 
9.5% at a concentration of 7.3 nmol/L. The CVs for within-batch 
imprecision are 15% at a concentration of 0.3 nmol/L and 5.9% at a 
concentration of 2.5nmol/L. This method measures total extractable 
testosterone. Five participants were excluded: three participants had 
undetectable/unreliably low pT levels (<0.10 nmol/L), one sample was 
unusable, and one was an outlier with a very high pT value (19.50 
nmol/L; visible in Fig. 1). As expected, mean pT levels were significantly 
higher in males compared to females (mean sex difference = 0.57 
nmol/L, t = − 7.66, p < 0.001, Cohen’s d = 1.51; Table 1) although the 
distribution of pT values varied considerably between the sexes (Fig. 1). 
PT was standardized across the full sample. 
2.3. Autism spectrum quotient (AQ) 
Adolescents completed the self-report Adult AQ (Baron-Cohen et al., 
2001) while parents completed the Adolescent AQ (Baron-Cohen et al., 
2006). Both are 50-item questionnaires with response outcomes on a 
4-point scale (definitely disagree, slightly disagree, slightly agree, defi-
nitely agree). Item wording was the same across the 2 versions of the AQ, 
with subject “I” in self-report simply changed to “he/she” in 
parent-report, allowing direct comparison between them (items listed in 
Table S10). Approximately half the items are worded to produce a 
“disagree” response, and half an “agree” response to avoid response bias. 
Only the valence (and not the strength) of the response was considered 
when scoring (i.e. slightly and strongly both equal 1 point). Five theo-
retical sub-scales assess domains of autism-related differences (higher 
scores corresponding to more differences): social skills, attention to 
detail, attention switching, communication and imagination (Baron--
Cohen et al., 2001). Each domain is assessed by 10 questions giving a 
maximum total AQ score of 50. 
The internal consistency for the AQ total is adequate (range of 
Cronbach’s alpha across studies 0.67–0.82; Austin, 2005; Hurst et al., 
2007). Cronbach’s alpha ranges for sub-scales are as follows: social skill 
(0.66–0.77), attention switching (0.41–0.67, attention to detail 
(0.60–0.66), communication (0.47–0.65), imagination (0.40–0.65; 
Baron-Cohen et al., 2001; Austin, 2005; Hurst et al., 2007). 
Participants were required to have either a parent- or self-report AQ 
(or both) for inclusion. Most (78%) participants had both versions of the 
AQ, so while the Adult-AQ has only been validated for individuals over 
16 (Baron-Cohen et al., 2001) and the Adolescent-AQ has only been 
Table 1 
Descriptive Statistics for Full Sample and Each Sex.   
Full Sample (N = 97) Females (n = 41) Males (n = 56) Sex Difference (Cohen’s D)1 
Variable N M SD Min-Max N M SD  N M SD 
pT (nmol/L) 97 0.67 0.47 .10–2.3 41 0.34 0.34  56 0.92 0.41 1.51 * ** 
Time of amnio. (weeks’ gestation) 50 16.64 1.48 14–21 15 16.47 1.06  35 16.71 1.64 0.17 
Maternal age 74 35.01 4.74 23–45 31 35.97 4.32  43 34.44 4.96 0.35 
Child age 96 15.61 1.77 13–21 41 15.80 1.78  55 15.46 1.77 0.22 
Pubertal Stage 96 3.30 0.45 1.8–4.0 41 3.61 0.3  55 3.07 0.39 1.55 * ** 
Pubertal Timing 96 0.00 0.28 -1.0–0.6 41 0.00 0.26  55 0.00 0.30 < 0.01 
Self-Report AQ             
Total 87 16.32 6.72 4–39 40 14.90 5.67  47 17.53 7.35 0.40 
Social Skill  2.40 2.41 0–10  2.02 2.07   2.72 2.65 0.29 
Communication  2.28 2.03 0–8  1.90 2.01   2.60 2.01 0.35 
Imagination  2.47 1.74 0–7  2.00 1.45   2.87 1.87 0.52 * 
Att. To Detail  5.06 2.16 0–9  5.22 2.11   4.91 2.22 0.14 
Att. Switching  4.11 2.01 0–10  3.75 1.81   4.43 2.13 0.34 
Parent-Report AQ              
Total 86 12.95 8.07 3–40 36 9.11 2.94  50 15.72 9.38  0.89 * ** 
Social Skill  2.01 2.38 0–10  0.94 0.98   2.78 2.78  0.83 * ** 
Communication  2.02 2.19 0–10  1.22 1.24   2.60 2.53  0.66 * * 
Imagination  2.06 1.96 0–9  0.92 0.94   2.88 2.23  1.15 * ** 
Att. To Detail  3.99 2.19 0–9  3.89 1.89   4.06 2.39  0.08 
Att. Switching  2.87 2.08 0–9  2.14 1.50   3.40 2.29  0.63 * * 
*p < 0.05. ** p < 0.01. ***p < 0.001. 
1Significance (*) derived from Welch’s Two-Sample T-Tests (t-test variant used for samples with potentially unequal variances). 
pT = prenatal testosterone; M = mean; SD = standard deviation 
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validated for those under 16 (Baron-Cohen et al., 2006), most partici-
pants had at least one version of the AQ that had been validated for their 
age-group. 
2.4. Age 
Participant ages ranged from 13 to 21 years (mean = 15.6, SD =
1.77). There was 1 participant with missing age which was imputed with 
the mean. We refer to all participants as adolescents given recent pro-
posals that the definition of adolescence should be extended to 10–24 
years, within which continued biological and social development occurs 
(Sawyer et al., 2018). 
2.5. Pubertal stage 
The Pubertal Developmental Scale (Petersen et al., 1988) was used to 
measure pubertal stage. This self-report questionnaire includes a series 
of items about growth spurt, body hair growth and skin changes for both 
males and females. Sex-specific questions include facial hair growth and 
voice change for males, and breast development and the onset of 
menarche for females. For each item, the participant responds on a 
4-point scale: 1 = not started, 2 = barely started, 3 = definitely under-
way, 4 = seems complete. Onset of menarche was a yes/no question, 
corresponding to scores of 4/1 respectively. Mean pubertal stage was the 
average of the 5 items. Adolescent self-reports on this scale have been 
validated, showing good consistency with parent-ratings on the same 
scale (Carskadon and Acebo, 1993; Koopman-Verhoeff et al., 2020; 
Herting et al., 2020), picture-based rating systems (Shirtcliff et al., 2009; 
Bond et al., 2006; Koopman-Verhoeff et al., 2020) physical examinations 
by a medical professional (Shirtcliff et al., 2009; Schmitz et al., 2004) 
and pubertal hormone levels (Shirtcliff et al., 2009; Braams et al., 2015; 
Herting et al., 2020). This scale also shows excellent internal consistency 
(Cronbach’s alpha = .93) and test-retest reliability (Intraclass correla-
tion coefficient = 0.87; Koopman-Verhoeff et al., 2020). 
2.6. Pubertal timing 
Pubertal timing was the deviation of an individual’s pubertal stage 
from the mean stage for their age and sex, within this sample. We 
regressed pubertal stage on age for males and females separately 
(standard linear regressions) and the residuals of these tests (Fig. S4) 
were taken to represent sex-specific variation in pubertal timing. This 
approach has been used by others to represent pubertal timing (Dorn 
et al., 2003; Ellis et al., 1999; Ellis and Garber, 2000; Ge et al., 2003; 
Siegel et al., 1999) and our average trajectories of age and pubertal stage 
align well with those from other studies (Gunnar et al., 2009; Klump 
et al., 2007; Smith-Woolley et al., 2017). Negative residuals correspond 
to developing slower than average; positive residuals correspond to 
faster development than average. While the terms fast vs slow (pubertal 
tempo) are used to represent variation in pubertal timing, this variable 
may also reflect differences in pubertal onset (early vs late onset), which 
could not be differentiated given cross-sectional measurement of pu-
bertal stage. 
2.7. Gestational confounds 
Certain gestational factors may be associated with pT levels and 
autistic traits and are therefore potential confounds. The time of 
amniocentesis (in weeks gestation) for instance is correlated with 
autistic traits in infants (Auyeung et al., 2010; Knickmeyer et al., 2005). 
Unfortunately, due to this data not being systematically recorded at the 
first wave of data collection, it was available for only a sub-sample 
(n = 50). Maternal age at birth (in years) was available for more par-
ticipants (n = 74) and was also controlled for due to previously reported 
associations with pT levels (Auyeung et al., 2012) and sex-typical 
behavior in children (Auyeung et al., 2009a). 
2.8. Statistics 
2.8.1. General approach 
All analyses were performed in R (R Core Team, 2012). Linear mixed 
models were used to predict AQ scores using the lmer function from the 
lme4 package (Bates et al., 2014). Parameters were estimated using 
REML (Restricted Maximum Likelihood). Both parent- and self-reported 
AQ scores were considered dual observations of the same latent 
construct (AQ score), which was achieved by including a random 
Fig. 1. Histogram and density plots for prenatal testosterone (nmol/L) for females (a) and males (b).  
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intercept for each subject (1|ID) and including rater a within-subject 
variable. Binary variables were centered (sex, rater; contrasts of − 0.5 
and 0.5). PT was standardized (centered and scaled) while pubertal 
stage was centered to retain original scale. 
While linear mixed models are robust to violations of distributional 
assumptions (Schielzeth et al., 2020), we also ran generalized linear 
mixed models using a gamma distribution to account for the positive 
skew in AQ scores (details in Supplementary Material). 
A power analysis, using R package simr, determined that our linear 
mixed model and sample size (n = 97, number of observations =170) 
had sufficient power (83%) to detect a main effect of pT on AQ similar in 
magnitude to that found in younger children (Auyeung et al., 2009b). 
Large (β = 12), moderate (β = 6) and small (β = 3) interactions between 
pT and our pubertal measures could be observed with power of 100%, 
60% and 20% respectively. The interaction between pT and sex was 
likely to be underpowered (required sample size for 80% power esti-
mated between 320 and 2000 participants). Allowing estimates to vary 
by sex is crucial to any test of testosterone effects, therefore we could not 
exclude the pT x sex interaction despite power issues. Details of power 
calculations are described in Supplementary Material. 
We calculated 95% confidence intervals for the Pearson’s correla-
tions between pT and AQ scores from our data and that of (Auyeung 
et al., 2009b) using the Fisher’s r-to-z transformation. 
2.8.2. Predicting AQ total 
Predictors included sex (m/f), rater (parent/self), (and continuous 
variables) pT, pubertal stage, pubertal timing, maternal age at birth and 
time of amniocentesis. To avoid multicollinearity between pubertal 
stage and pubertal timing (due to the latter being generated from the 
former), two separate models were run. The pubertal stage model 
included 4 main effects (pT, sex, rater, pubertal stage) and 2 interactions 
(pT-by-sex, pT-by-pubertal stage) at baseline. The pubertal timing 
model simply replaced pubertal stage with pubertal timing. Maternal 
age and time of amniocentesis were added in consecutive models (M2, 
M3) as their inclusion reduced the sample size to 74 and 50 respectively. 
Inclusion of a pT x sex interaction allows the slope of the pT-outcome 
relationship to differ for males and females which was deemed neces-
sary given differences in pT distribution observed across sex (Fig. 1) and 
the potential for sex differences in androgen signaling. Inclusion of in-
teractions between pT and puberty measures allowed us to explore 
whether the effects of pT on AQ changed across pubertal maturation 
(pubertal stage) or whether the effect differed between on average “fast” 
and “slow” developers (pubertal timing). Our hypothesis was supported 
if we found a significant effect of pT on AQ, or an interaction of pT-by- 
sex on AQ (such that the correlation existed in one sex but not the other). 
If no association was observed, equivalence tests were carried out to 
support absence of a meaningful effect with regards to an a priori effect 
size (Lakens, 2017). Given that there were 3 pT-related effects of interest 
(main effect of pT, interaction of pT-by-sex and interaction of 
pT-by-pubertal stage/timing), we applied a more conservative 
Bonferroni-adjusted threshold of significance (0.05/3 = 0.0167) when 
interpreting results of this model. 
We tested whether the relationship between pT and AQ total score 
was better described as quadratic (versus linear). An pT2 term was 
included as an additional fixed effect. A quadratic effect of pT on AQ 
total would be supported if the model including a quadratic term was a 
better model fit to the data than the model including linear terms only 
(according to Log Likelihood, AIC & BIC) and if the pT2 term itself was 
significant. 
Sensitivity analyses were performed to verify results of the linear 
mixed models: (1) simpler models predicting AQ from pT (less cova-
riates and rater-stratified models) (2) sex-stratified analyses (3) gener-
alized linear mixed models to account for violations of assumptions of 
normality and homoscedasticity and (4) a repeat of main analyses 
without participants with an autism diagnosis (n = 1). 
2.8.3. Predicting AQ sub-scores 
The five AQ subscales were dependent variables in five separate 
tests. We had no specific hypotheses about the how pT would relate to 
the AQ subscales therefore, on the basis of AQ total results, we included 
pubertal timing only (not pubertal stage) in prediction models of AQ 
subscales to restrict the number of tests performed. The baseline model 
(M1) used to predict each AQ subscale therefore included 4 main effects 
(pT, sex, rater, pubertal timing) and 2 interactions (pT-by-sex, pT-by- 
pubertal timing). In subsequent models, we also controlled for 
maternal age at birth (M2) and time of amniocentesis (M3). We report 
Bonferroni corrected significance levels (p = .01) for reference (0.05/5 
sub-scales). We also conducted sensitivity analyses with these sub-score 
results (as in 2.8.2). 
3. Results 
3.1. Descriptive Statistics 
Table 1 shows that there were significant sex differences in pT levels 
(males > females), pubertal stage (females > males), parent-reported 
AQ totals (males > females) and the self-reported AQ subscale of 
imagination (males > females). Whilst self- and parent-ratings on the AQ 
total were significantly correlated (r(74) = .42, p < .001), there was 
also a significant difference whereby adolescents rated themselves 
higher than parents on average (t(75) = − 4.38, p < .001; Table 1). 
Maternal age at birth was significantly correlated with pT (r (71)= −
0.35, p = .002) but not AQ totals. Time of amniocentesis was weakly 
correlated with both amniotic pT levels (r (48) = 0.24, p = 0.10) and 
rater-averaged AQ totals (r (48)= − 0.27, p = .05). 
3.2. Inferential statistics 
3.2.1. pT and AQ Total 
Using linear mixed models, no significant main effect of pT on AQ 
total was observed when controlling for sex, pubertal stage/timing, AQ 
rater (M1), time of amniocentesis (M2) and maternal age (M3). No 
significant interaction between pT and sex was observed either 
(Table 2). The Pearson’s correlation between pT and rater-averaged AQ 
totals for males was r = − 0.11 (p = .44, n = 56) and for females was 
r = 0.17 (p = .30, n = 41). No significant correlation was observed be-
tween pT and specifically parent-reported AQ total (male r = − 0.07, 
p = 0.65; female r = 0.08, p = 0.65) or self-reported AQ total (male 
r = − 0.15, p = 0.32; female r = 0.23, p = 0.15). The quadratic rela-
tionship between pT and AQ total was not significant i.e., the pT2 term 
was not significant and its inclusion did not improve model fit 
(Table S1). The hypothesis that pT would correlate positively with AQ 
total was therefore not supported. The 95% confidence interval for the 
correlation between pT and rater-averaged AQ scores (CI = − 0.03 to 
0.36, r = 0.17, p = 0.09) only overlapped to a small extent with the 
interval previously reported in younger children (CI = 0.30–0.51, 
r = 0.41, p < 0.01; Auyeung et al., 2009b). Sensitivity analyses, specif-
ically a set of simpler models (Tables S3-5), sex-stratified analyses 
(Table S6-7) and a generalized linear mixed model (Table S8), supported 
this null finding. Using Auyeung et al. (2009)’s point estimate (r = .41) 
as the upper bound of an equivalence test, we found that our observed 
effect size (on both parent-reported AQ and rater-averaged AQ scores) 
were significantly within the equivalent bounds. Our observed effect 
was therefore not equal to, or greater than, the point estimate reported 
by Auyeung et al. (2009). 
Table 2 shows the interaction between pT and pubertal stage on AQ 
totals was not significant at the Bonferroni-corrected threshold (0.0167) 
in the baseline model M1 or after adjusting for maternal age (M2) but 
was significant in M3, adjusted for both maternal age and time of 
amniocentesis (β = 10.19, SE = 3.31, t = 3.08, p = .003). Fig. 2 sug-
gested that the correlation between pT and AQ total became increasingly 
positive the later the pubertal stage. Sensitivity analyses suggested this 
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Table 2 
Predicting AQ total. Fixed effect estimates β (and standard errors). P-values derived from Wald tests. M1-M3 denote models adjusting for increasing numbers of 
covariates. Pubertal stage and timing models split to avoid multicollinearity.    





M1 + maternal 
age 
M3 






M1 + maternal 
age 
M3 
M2 + time of 
amniocentesis 
M1 pT -0.97(1.76) -0.33(1.95) -1.87(4.31) -1.04(1.74) -0.43(1.92) -1.98(4.20)   
p = 0.59 p = 0.87 p = 0.67 p = 0.56 p = 0.83 p = 0.64  
Sex 7.48(3.19) 5.22(3.46) 5.64(8.47) 6.11(3.01) 4.33(3.24) 6.38(7.84)   
p = 0.02 p = 0.14 p = 0.51 p = 0.05 p = 0.19 p = 0.42  
Rater -3.61(0.83) -3.53(0.91) -3.09(1.25) -3.67(0.83) -3.54(0.92) -3.13(1.26)   
p < 0.001 p < 0.001 p = .02 p < 0.001 p < 0.001 p = 0.02  
pT x Sex 1.72(3.67) 2.15(3.94) 9.50(8.48) -0.60(3.49) -1.00(3.71) 3.47(8.43)   
p = 0.64 p = 0.59 p = 0.27 p = 0.87 p = 0.79 p = 0.69  
Pubertal Stage 2.59(1.79) 1.56(2.00) -1.67(2.62) – – –   
p = 0.15 p = 0.44 p = 0.53     
pT x Pubertal Stage 3.94(2.42) 5.65(2.61) 10.19(3.31) – – –   
p = 0.11 p = 0.04 p = 0.003     
Pubertal Timing – – – 2.28(2.14) 2.06(2.21) -1.05(2.63)      
p = 0.29 p = 0.36 p = 0.69  
pT x Pubertal Timing – – – 5.98(2.58) 7.28(2.74) 11.15(3.27)      
p = 0.02 p = 0.008 p = 0.001 
M2 Maternal Age at Birth – -0.01(0.16) -0.12(0.20) – 0.03(0.16) -0.05(0.20)    
p = 0.96 p = 0.56  p = 0.83 p = 0.79 
M3 Time of Amniocentesis (gestational 
weeks) 
– – -2.07(0.61) – – -2.02(0.59)    
p = 0.001   p = 0.001  
# Observations 170 139 94 170 139 94  
# Participants 95 73 49 95 73 49  
Log Likelihood -551.02 -446.96 -297.37 -549.91 -445.71 -296.48  
AIC 1120.04 913.91 616.74 1117.83 911.42 614.95  
BIC 1148.26 943.26 644.72 1146.05 940.77 642.93 
pT = Prenatal testosterone; AIC = Akaike Information Criterion; BIC = Bayesian Information Criterion. 
Bonferroni-adjusted p-threshold = .0167 
Fig. 2. Effects of pT on AQ totals for 3 
different stages of pubertal develop-
ment. Full sample results (top) and sex- 
stratified (bottom). 
Note: Three discrete scores along the 
continuous Pubertal Development Scale 
reflect puberty that has “barely started” 
(2), “definitely started” (3), and is 
“complete” (4). AQ values on the y-axis 
capture the average of parent- and self- 
reported AQ. Note higher scores on the 
AQ correspond to more autistic traits. 
Error bands refer to standard errors. 
Estimates taken from M2   
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interaction was stronger in males (Tables S6-7) and in self-reported AQ 
scores (Tables S4-5) but generalized linear mixed models found the 
interaction was not significant in any model (M1-M3), limiting the 
robustness of this finding. 
Table 2 also shows an interaction between pT and pubertal timing on 
AQ total which was significant at the Bonferroni-corrected threshold 
after correction for maternal age (M2: β = 7.28, SE = 2.74, t = 2.65, 
p = 0.01; N = 73) and time of amniocentesis (M3: β = 11.15, SE = 3.27, 
t = 3.41, p = 0.001; N = 49) but not in the baseline model M1. Fig. 3 
shows that pT was positively associated with AQ total for individuals 
who were fast developers (i.e. advanced pubertal stage for their age 
relative to the rest of this sample). Those who were ‘slow developers’ (i. 
e. relatively under-developed for their age) showed a negative correla-
tion between pT and AQ total. Those developing at an average speed for 
their age showed a weak negative correlation between pT and AQ. This 
interaction was also subjected to several sensitivity analyses: rater-split 
tests showed the interaction was stronger for self-reported AQ than 
parent reports (Table S4-5); sex-stratified analyses showed the interac-
tion was strongest in males (Table S6-7; Fig. S2) and generalized linear 
mixed models showed the interaction to be attenuated and non- 
significant at the corrected threshold once the skew in outcome was 
accounted for (Table S8). On balance, the reliability of this interaction 
should thus be interpreted with caution given the lack of guiding hy-
pothesis, low power, and due to lack of support from alternative 
modeling (generalized linear mixed analysis). However, for explorative 
purposes we investigated the pT x pubertal timing interaction among the 
AQ subscales. 
Of all predictors of AQ total, rater had the most reliable effect. On 
average, adolescents rated themselves over 3.0–3.7 points higher than 
their parents did on the 50-point AQ scale (Table 2). Sex also had a 
significant effect in M1 with males having higher AQ totals than females, 
but this became non-significant after controlling for maternal age at 
birth (M2). 
3.2.2. pT and AQ subscales 
To limit the number of tests performed on AQ subscales, we explored 
the pubertal timing model only, as pubertal timing had shown more 
reliable interaction effects with pT on AQ total score, and as pubertal 
variables were highly correlated. Fig. 4 depicts the interaction between 
pT and pubertal timing on each AQ subscale. The interaction between pT 
and pubertal timing was strongest for social skill, and this effect was 
significant in the baseline model (M1) and after controlling for gesta-
tional confounds (M2, M3) at a corrected p-threshold (M1: β = 2.20, SE 
= 0.83, p = 0.008; M2: β = 2.52, SE = 0.90, p = 0.006; M3: β = 4.24, SE 
= 1.14, p < 0.001). Fig. 4 shows, as with the AQ total, that pT was 
positively associated with social skill differences in individuals who 
went through puberty faster than average, and pT was inversely asso-
ciated with these differences in those who progressed through puberty 
slower than average. For those with average pubertal timing for their sex 
and age, there was little correlation between pT and social skills. Fig. S1, 
suggested this interaction was more reliable in males compared to fe-
males, an observation which was supported by sex-stratified results 
(Tables S6-7). Generalized mixed models found the interaction between 
pT and pubertal timing on social skills to be significant at corrected 
thresholds across all levels of covariate adjustment (M1-M3; Table S9), 
supporting the robustness of this finding to model variation. Full AQ 
subscale results are provided in Table S2. 
An interactive effect of pT and pubertal timing was also observed for 
the communication subscale, though it was only significant at the cor-
rected threshold for the fully-adjusted model in the restricted sample 
Fig. 3. Effects of pT on AQ totals for 3 levels of pubertal timing. Full sample results (top) and sex-stratified (bottom). 
Note: Lines represent three levels of pubertal timing: 0.5 (“fast”), 0 (“average”) and -0.5 (“slow”). AQ values on the y-axis capture the average of parent- and self- 
reported AQ. Note higher scores on the AQ correspond to more autistic traits. Error bands refer to standard errors. Estimates from M2. 
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(M3; n = 49) in both linear mixed models (Table S2; M3: β = 3.34, SE =
0.86, p < 0.001) and generalized linear mixed models (Table S9; M3: 
β = 2.09, SE = 0.72, p = 0.006), therefore this result should be inter-
preted with caution. 
No significant main effects of pT were observed for any subscale. 
There was just one individual in the analysis who had been diag-
nosed with an autism spectrum condition. All results remained highly 
similar when this individual was excluded (Supplementary Material, 
Sensitivity Analysis 4). 
4. Discussion 
This is the first study to examine the effect of amniotic-derived pT 
levels on autistic traits in adolescence and the first to test interactions 
between pT and pubertal development. We did not find a positive cor-
relation between pT and autistic traits (measured by the AQ) in the full 
sample, or either sex. A number of sensitivity analyses verified this null 
finding (Table S3-S8; Figs. S2-S3) and equivalence tests supported the 
absence of a meaningful effect. Exploratory findings indicated that the 
effects of pT were moderated by pubertal timing, particularly in males, 
such that having both high pT and early/fast pubertal development was 
linked with the highest AQ scores while having both high pT and slow/ 
late puberty was linked with lowest AQ scores (Fig. 3). However, the 
evidence supporting this interaction was preliminary, had limited sta-
tistical robustness and requires replication. Further exploratory analysis 
of the AQ subscales suggested that this interaction between pT and 
pubertal timing was most relevant to social skills (Fig. 3). 
4.1. Direct effect of pT on autistic traits 
The lack of association between amniotic pT and AQ contrasts with 
some previously reported positive correlations between pT and autism- 
related traits in infants (Lutchmaya et al., 2001, 2002; Auyeung et al., 
2010) and young children (Chapman et al., 2006; Auyeung et al., 2006, 
2009b, 2012; Knickmeyer et al., 2005, 2006b). Most relevantly, a pos-
itive correlation between pT and parent-report AQ (total score and 
sub-scores) was observed in children aged 6–10 (Auyeung et al., 2009b), 
some of whom also took part in the current study. Given the Auyeung 
et al. study and ours were based on largely overlapping samples and 
both used the AQ to measure autistic traits, differences in results could 
have arisen from differences in sample size (n = 97 Vs Auyeung et al., 
2009b n = 235) or sample age (~ 16 years Vs ~ 9 years in Auyeung 
et al., 2009b). A power analysis determined our study had sufficient 
power (83%) to detect an effect similar in magnitude to that found in 
Auyeung et al., 2009b (see Methods 2.7.1) and our results do not indi-
cate even a weak positive association (Table 2) therefore differences in 
results between our study and those of Auyeung et al. (2009b) are more 
likely to have arisen from differences in the age/developmental stage of 
the participants. 
It may be that increased peer comparison and social motivation 
during adolescence alters how individuals score on the AQ. There have 
been no longitudinal studies of AQ across adolescence however puberty 
has been shown to parallel significant changes in social emotion pro-
cessing which may counteract, or at least interact with, autistic traits 
(Goddings et al., 2012). 
The prenatal sex steroid theory of autism does not make explicit 
hypotheses about the nature of effects into, or beyond puberty, as this 
has never been tested, however our results suggest the positive corre-
lation between pT and autistic traits found in pre-pubertal children may 
not generalize to adolescents. Current theories may need to be revised to 
acknowledge possible developmentally dependent effects of prenatal 
hormones on autism-related traits. Future studies should investigate 
whether the association between pT and autistic traits remains null into 
adulthood and how associations between other steroids (e.g. estrogens) 
and autistic traits (Baron-Cohen et al., 2019; Tsompanidis et al., 2021) 
are affected by adolescence. 
Fig. 4. Effects of pT on the AQ subscales for 3 levels of pubertal timing. 
Note: Lines represent three pubertal timing subgroups: 0.5 (“fast”), 0 (“average”) and − 0.5 (“slow”). AQ values on the y-axis capture the average of parent- and self- 
reported AQ. Error bands refer to standard errors. Estimates from M2 models tested in the full sample. 
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4.2. Interaction of pT and puberty on autistic traits 
Fig. 3 shows the interaction between pT and pubertal timing, in 
which pT levels are positively correlated with AQ total scores for those 
who experienced puberty relatively faster than their peers, while pT is 
inversely correlated with AQ total scores in those with slow (or delayed) 
puberty. The interaction was stronger in self-reported AQ than parent- 
reported AQ (Tables S4-5) and was driven by males (Table S6-7; 
Fig. S2). Analysis of the AQ sub-scales suggest the interaction may apply 
to social skills (Fig. 4) more than the sum of all traits (AQ total). How-
ever, the robustness of interactions between pT and pubertal variables 
(stage and timing) were not supported by generalized linear mixed 
models which accounted for the non-normally distributed outcome (AQ) 
and residuals. Our analysis was also likely underpowered (~60%, sup-
plementary material) to detect such interaction effects. 
Findings from other human studies support the plausibility of our 
trend interaction between pT and pubertal timing on autistic traits. One 
study in 14–16-year-old adolescents showed prenatal and pubertal 
testosterone levels had an interactive effect on male-typical patterns of 
brain lateralization during a visuospatial task (Beking et al., 2018). 
Specifically, in those with low pT exposure, pubertal testosterone 
increased or “masculinized” lateralization while it decreased or 
“de-masculinized” lateralization in those with high pT. While Beking 
and colleagues measured pubertal testosterone rather than pubertal 
timing (although they are likely correlated; Marceau et al., 2019; 
Shirtcliff et al., 2009), both our findings and those of Beking et al. 
support the idea that the effects of pT may interact with pubertal factors 
to influence sexually differentiated traits. Peper et al. (2009) found that 
putative effects of pT due to having a male twin in utero were seen in 
brain volumes in children aged 9 but not in adults, suggesting that the 
effect of pT on brain volume does not persist beyond adolescence. 
It may be that both high pT and early/fast pubertal timing are by- 
products of a polygenetic tendency to autism. The majority of genetic 
contribution to autism is likely due to common variants (Gaugler et al., 
2014) which may influence both the production of fetal steroids and 
pubertal timing. Alternatively, pubertal timing may be an indirect 
measure of the prenatal endocrine environment and the interaction 
between pT and pubertal timing may capture interaction of multiple 
steroids or chronicity of high pT throughout gestation. Of potential 
relevance, pubertal factors only had a statistical effect on AQ scores for 
higher levels of pT levels (Figs. 2–4). In animal models, prenatal 
administration of testosterone and glucocorticoids delay the onset of 
puberty (Cruz and Pereira, 2012; Smith and Waddell, 2000; Abbott 
et al., 2009; Padmanabhan et al., 2006) and prenatal blocking of 
androgen signaling (via flutamide) results in earlier onset of puberty in 
rhesus monkeys (Herman et al., 2006). In humans, females with PCOS 
are more likely to have been exposed to high pT in utero (Risal et al., 
2019) and to experience earlier onset of puberty (Ibáñez et al., 2009). 
Prenatal exposure to endocrine-disrupting chemicals from common 
household and hygiene products (e.g. pthalates; Harley et al., 2018) can 
also alter pubertal timing. 
Table 2 shows that the main effect of pubertal timing on AQ total was 
not significant. Our results may therefore be consistent with a “double- 
hit” model of autistic traits (Picci and Scherf, 2015) in which the com-
bination of a gestational hit (high pT levels) and an adolescent hit 
(pubertal development earlier/faster than average) is linked with the 
highest AQ scores. 
4.3. Social Vs non-social subscales 
Amongst the 5 sub-domains of the AQ, the largest pT-by-pubertal 
timing interaction was observed for social skills (Fig. 4). The social 
skills scale of the AQ consists of items such as “I prefer to do things with 
others rather than on my own” and “I find it hard to work out people’s in-
tentions” (Table S10). This effect was significant at the Bonferroni- 
corrected alpha level in all levels of adjustment of the linear mixed 
model (M1-M3; Table S2) and in sensitivity analyses which accounted 
for the skew in AQ scores (generalized linear mixed models M1-M3; 
Table S9). As with the AQ total, the interaction was stronger in males 
compared to females (Fig. S1; Tables S6-7). Weaker interactive effects 
were observed for communication and attention-switching which were 
not significant at the corrected threshold. Social and non-social aspects 
of autism have been shown to be dissociable on the basis of genetics 
(Warrier et al., 2019; Happé and Ronald, 2008) and factor analysis 
(Hoekstra et al., 2008). The stronger interaction effects of pT on social 
aspects of autism is consistent with a neuroimaging study on a sub-group 
of our sample (Lombardo et al., 2018). It suggested a stronger effect of 
pT on social brain networks (default mode network) in adolescence than 
other networks underlying emotion, reward,or language. While the 
interaction effect of pT and pubertal timing on social skills needs to be 
replicated in larger cohorts, our results provide preliminary evidence 
that pT and pubertal factors may be relevant to social aspects of autism, 
particularly in males. 
4.4. Rater discordance 
AQ scores varied significantly between parent- and self-reports, 
which is often the case for reports of mental health in older adoles-
cents (Stratis and Lecavalier, 2015). Despite equivalency of items and 
scoring methods across versions, adolescents rated themselves 3–4 
points higher on the AQ (range 0–50) than their parents (Table 2) and 
this rater-based discrepancy was stronger for females (e.g., rater 
β = 5.73–5.91) than males (rater β = 1.67–1.96; Table S6-7). This sex 
difference may be explained by under-reporting of female autistic traits 
by parents due to “camouflaging” (e.g. Kenyon, 2014). The extent of 
rater discordance on the AQ highlights the importance of including 
multiple reports for this age-group. To improve construct validity even 
further, we recommend that future studies incorporate expert-rated as-
sessments of autism spectrum traits. 
4.5. Strengths and limitations 
Limitations include the non-exhaustive list of autism-linked traits 
included in the AQ and the relatively small sample size limited our range 
of pT values. In particular, female pT values were low with narrow 
distribution (Fig. 1), making it difficult to conclude whether there was 
no female effect or whether the pT variance was too small to detect ef-
fects. A second limitation is our singular estimate of T from amniotic 
fluid, which represents only one steroid analyte within a defined time 
window. Rodeck et al. (1985) also found that amniotic pT did not 
correlate with fetal serum pT taken around the same time. Given re-
ported effects of other steroid hormones (e.g. estrogens) on childhood 
autism (Baron-Cohen et al., 2015, 2019; Tsompanidis et al., 2021), 
future studies using amniotic-derived pT should aim to measure a range 
of steroid hormones. Third, ascertainment bias may be present and limit 
the generalizability of these results, as the women referred to amnio-
centesis between 1996 and 1999 are unlikely to represent the typical 
population of expectant women. Fourth, our sample overlaps with those 
previously studied (Lutchmaya et al., 2001, 2002; Auyeung et al., 2006, 
2009b; Chapman et al., 2006; Knickmeyer et al., 2005, 2006b), although 
this is the first study of the pT-autistic traits link in the cohort during 
adolescence (Lombardo et al., 2018). The shortage of data from other 
cohorts is a limitation to the generalizability of these findings. Finally, 
pubertal development was measured by self-report only and while this 
measure has shown good consistency with more objective measures and 
parent-ratings (see Section 2.5) some measurement error likely remains. 
A core strength of this study is its use of amniotic-derived pT, a direct 
measure of a specific hormone at a defined window of gestation rather 
than a retrospective proxy. Amniotic data is an increasingly valuable 
resource as the amniocentesis procedure has been slowly phased out in 
favor of serum karyotyping and ultrasound examinations. Other 
strengths of the study are the inclusion of dual reports of autistic traits 
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(doubling observations and allowing inclusion of individuals with either 
observation) and the inclusion of multiple trait scales (communication, 
attention-to-detail, etc.). Finally, the use of multiple statistical models 
with different underlying assumptions (linear mixed models; general-
ized linear mixed models; sex-stratified tests) allowed us to probe the 
robustness of findings. 
4.6. Conclusion 
This is the first study to investigate behavioral correlates of mid- 
gestational pT in adolescents and young adults, and the first to assess 
the contribution of puberty. Our findings suggest that the positive cor-
relation between pT and autistic traits, previously observed in infants 
and children of the same cohort, does not persist into adolescence. 
However, an exploratory analysis suggested pT and pubertal timing may 
have interactive effects on autistic traits. This interaction was stronger 
for social aspects of autism and for males. This finding was explorative 
and additional research in both humans and animals is needed to test its 
robustness. Our results also highlight the importance of including pu-
bertal measures and multi-rater behavioral assessments when investi-
gating hormone-behavior links in adolescents. 
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